Instead of our regularly scheduled (in reality intermittently posted) blog on this site, I’ll direct you to a guest blog I wrote for the Washington Post. The topic is one I’ve touched on before: the biggest impact of Cas9 will not be in the clinic, but in its ability to accelerate fundamental biological discovery across numerous labs. Which is not to say that curing genetic disease is a small thing. It’s a sea-change for our relationship with our own genomes and something I’m personally very passionate about. But I think it’s undeniable that thousands of labs all using democratized gene editing to make new discoveries will snowball in a big way.